DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
Oncotarget
; 6(32): 32494-508, 2015 Oct 20.
Article
in En
| MEDLINE
| ID: mdl-26378812
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tretinoin
/
Myelodysplastic Syndromes
/
Leukemia, Promyelocytic, Acute
/
Adjuvants, Immunologic
/
Cancer Vaccines
/
Vaccines, DNA
/
Neoplasms, Experimental
Type of study:
Prognostic_studies
Language:
En
Journal:
Oncotarget
Year:
2015
Document type:
Article
Affiliation country:
France
Country of publication:
United States